Indian Journal of Gastroenterology 2018–2022: Looking back from the Editor’s desk!

[1] Philips CA(2018)Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis Indian J Gastroenterol. 37 215-225

[2] Phadke N(2018)A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: a pilot study Indian J Gastroenterol 37 416-423

[3] Ganesan K(2020)Poor outcomes in patients with cirrhosis and corona virus disease-19 Indian J Gastroenterol 39 285-291

[4] Ghoshal UC(2021)Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India Indian J Gastroenterol 40 144-153

[5] Srivastava D(2021)miR-222 regulates cell growth, apoptosis, and autophagy of interstitial cells of Cajal isolated from slow transit constipation rats by targeting c-kit Indian J Gastroenterol 40 198-208

[6] Misra A(2018)Dietary practices and inflammatory bowel disease Indian J Gastroenterol. 37 284-292

[7] Shalimar EA(2020)Epidemiology of non-alcoholic fatty liver disease in Asia Indian J Gastroenterol 39 1-8

[8] Vaishnav M(2021)Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation Indian J Gastroenterol 40 5-21

[9] Goyal O(2014)A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome foundation working team on cross-cultural, multinational research Neurogastroenterol Motil. 26 1368-1385

[10] Nohria S(undefined)undefined undefined undefined undefined-undefined

[1] Philips CA(2018)Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis Indian J Gastroenterol. 37 215-225

[2] Phadke N(2018)A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: a pilot study Indian J Gastroenterol 37 416-423

[3] Ganesan K(2020)Poor outcomes in patients with cirrhosis and corona virus disease-19 Indian J Gastroenterol 39 285-291

[4] Ghoshal UC(2021)Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India Indian J Gastroenterol 40 144-153

[5] Srivastava D(2021)miR-222 regulates cell growth, apoptosis, and autophagy of interstitial cells of Cajal isolated from slow transit constipation rats by targeting c-kit Indian J Gastroenterol 40 198-208

[6] Misra A(2018)Dietary practices and inflammatory bowel disease Indian J Gastroenterol. 37 284-292

[7] Shalimar EA(2020)Epidemiology of non-alcoholic fatty liver disease in Asia Indian J Gastroenterol 39 1-8

[8] Vaishnav M(2021)Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation Indian J Gastroenterol 40 5-21

[9] Goyal O(2014)A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome foundation working team on cross-cultural, multinational research Neurogastroenterol Motil. 26 1368-1385

[10] Nohria S(undefined)undefined undefined undefined undefined-undefined